Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Management of leprosy in the context of COVID‑19 pandemic: Recommendations by SIG leprosy (IADVL academy)

Rathod S, Suneetha S, Narang T, et al. Indian Dermatology Online Journal. 2020; 11 (3) : 345-348.
Download PDF
Publication

The Correlation of Semmes–Weinstein Monofilament Test with the Level of P-75 Neurotrophin as Marker of Nerve Damage in Leprosy

Widasmara D, Panjarwanto DA, Sananta P. Informa UK Limited. Clinical, Cosmetic and Investigational Dermatology. 2020;
Download PDF
Publication

Prevention of Disability in Children Living with Leprosy-Positive Parents: A Case Report

Wardhani RK, Harini M, Wahyuni LK, et al. Journal of Disability Studies. 2020; 6 (1) : 33-35.
Download PDF
Publication

Health-related quality of life associated with erythema nodosum leprosum in Purulia, West Bengal, India

Darlong J, Govindharaj P, Mahato B, et al. Leprosy review. 2020; 91 (1) : 100-107.
Download PDF
Publication

Difference in size of leprosy pedis ulcer injury before and after therapy at leprosy hospital Donorejo, Jepara Regency

Kirana PW, Muslimin M, Nugroho TW, et al. DIPONEGORO MEDICAL JOURNAL. 2020; 9 (4) : 357-365.
Download PDF
Publication

A study of household contacts of persons affected by leprosy with a high bacterial index

Kumar S, Kumar A, Govindharaj P. Leprosy review. 2020; 91 (1) : 56–62.
Download PDF
Publication

Nail Changes in Leprosy: An Observational Study of 125 Patients.

Rajput C, Nikam B, Gore S, et al. Indian dermatology online journal. 2020; 11 (2) : 195-201.
Publication

Late leprosy reaction presenting as erythema multiforme-like erythema nodosum leprosum with underlying rifampicin resistance and its potential implications.

Sardana K, Kulhari A, Mathachan S, et al. International journal of mycobacteriology. 2020; 9 (2) : 226-228.
Download PDF
Publication

Clinicobacteriological evaluation of leprosy patients with 1-5 skin lesions.

Ansari A, Saxena K, Singh K, et al. International journal of mycobacteriology. 2020; 9 (2) : 209-211.
Download PDF
Publication

A Clinical and Histopathological Correlation among Leprosy Patients (in this Post Elimination Era) Attending Tertiary Referral Centre

Thombare MM, Kote R, Gugle A, et al. Informatics Publishing Limited. MVP Journal of Medical Sciences. 2019; 6 (2) : 103-108.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 118
  • Next page ››
Subscribe to South-East Asia Region (SEAR)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD